Long term reduction of cardiovascular risk factors associated with three hour daily dialysis: A prospective, cohort

Steven G Achinger1,2, Juan Carlos Ayus3

  • 1Department of Nephrology, Watson Clinic, LLP, Lakeland, Florida, USA.

Hemodialysis International. International Symposium on Home Hemodialysis
|June 1, 2023
PubMed

Insights

Daily hemodialysis (DHD) offers long-term cardiovascular benefits over conventional hemodialysis (CHD). This study shows DHD significantly reduces blood pressure and improves mineral metabolism and anemia in patients over four years.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Internal Medicine

Background:

  • Conventional hemodialysis (CHD) has known effects on cardiovascular risk factors.
  • Previous studies indicated short-term benefits of daily hemodialysis (DHD) on left ventricular hypertrophy and mineral metabolism.
  • Long-term prospective data on DHD's impact on these cardiovascular risk factors were lacking.

Purpose of the Study:

  • To investigate the long-term (4-year) effects of daily hemodialysis (DHD) compared to conventional hemodialysis (CHD) on key cardiovascular risk factors.
  • To assess changes in left ventricular mass index (LVMI), blood pressure, hemoglobin, and mineral metabolism.

Main Methods:

  • A 4-year prospective cohort study comparing DHD (six 3-hour sessions/week) with CHD (three 4-hour sessions/week).
  • Included 26 DHD patients and 51 matched CHD patients, with 15 DHD and 26 CHD completing the 4-year follow-up.
  • Measured LVMI, blood pressures, hemoglobin, and mineral metabolism markers.

Main Results:

  • DHD patients exhibited significantly lower systolic and diastolic blood pressures at 4 years compared to CHD patients (p < 0.05).
  • Fewer DHD patients required anti-hypertensive medication (50% vs. 80%, p < 0.05).
  • DHD was associated with better achievement of mineral metabolism goals for phosphorus and calcium-phosphorus product (adjusted HR 3.6, p=0.002 and adjusted HR 3.66, p=0.001, respectively).
  • A trend towards lower LVMI was observed in the DHD group (p=0.23), and improvements in hemoglobin persisted.

Conclusions:

  • Daily hemodialysis is associated with sustained, long-term improvements in cardiovascular risk factors, including blood pressure, mineral metabolism, and anemia.
  • These findings suggest DHD may be a beneficial alternative for managing cardiovascular health in hemodialysis patients.
  • Further research could explore the impact of DHD on LVMI and overall cardiovascular outcomes.
Abstract

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
52
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
391
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
43
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
51
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
72
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
48